Approval · Notice of Compliance 9162 · 2007
ENTOCORT: Notice of Compliance 9162
Issued November 7, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9162
- Date
- November 7, 2007
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Requested studies re maintenance of remission of crohn's disease
- Therapeutic class
- Glucocorticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTOCORT | Not yet assigned | — |
Medicinal ingredients
- BUDESONIDE 3 MG per CAP